The largest vaccine manufacturing plant in the southern hemisphere is to be built in Melbourne.
A new flu vaccine manufacturing plant is intended to guard Australians against future pandemics, providing long-term access to influenza and fever vaccines.
It will also provide antivenoms for some of Australia's most deadly creatures.
The federal government has struck a $1 billion, 12-year deal with a subsidiary of pharmaceutical company C-S-L, which was formerly the Commonwealth Serum Laboratories but privatised and listed on the Australian Securities Exchange in 1994.
The subsidiary company, Seqirus, is to invest $800 million to develop a hi-tech vaccine manufacturing facility near Melbourne airport to replace its more than 60-year-old Parkville site.
